B. Riley Securities Downgrades Angel Oak Mortgage to Neutral, Lowers Price Target to $10
B. Riley Securities analyst Matt Howlett downgrades Angel Oak Mortgage (NYSE:AOMR) from Buy to Neutral and lowers the price target from $15 to $10.
Alliance Global Partners Downgrades Alimera Sciences to Neutral, Lowers Price Target to $4.5
Alliance Global Partners analyst James Molloy downgrades Alimera Sciences (NASDAQ:ALIM) from Buy to Neutral and lowers the price target from $11 to $4.5.
Evercore ISI Group Downgrades Kimco Realty to In-Line, Announces $22 Price Target
Evercore ISI Group analyst Steve Sakwa downgrades Kimco Realty (NYSE:KIM) from Outperform to In-Line and announces $22 price target.
Seaport Global Downgrades Evergy to Neutral
Seaport Global analyst Angie Storozynski downgrades Evergy (NYSE:EVRG) from Buy to Neutral.
Credit Suisse Downgrades Xcel Energy to Neutral, Announces $68 Price Target
Credit Suisse analyst Nicholas Campanella downgrades Xcel Energy (NASDAQ:XEL) from Outperform to Neutral and announces $68 price target.
Morgan Stanley Downgrades MongoDB to Equal-Weight, Lowers Price Target to $215
Morgan Stanley analyst Sanjit Singh downgrades MongoDB (NASDAQ:MDB) from Overweight to Equal-Weight and lowers the price target from $368 to $215.
Raymond James Downgrades Regions Financial to Market Perform
Raymond James analyst Michael Rose downgrades Regions Financial (NYSE:RF) from Outperform to Market Perform.
Raymond James Downgrades Alignment Healthcare to Market Perform
Raymond James analyst John Ransom downgrades Alignment Healthcare (NASDAQ:ALHC) from Outperform to Market Perform.
Raymond James Downgrades Oak Street Health to Market Perform
Raymond James analyst John Ransom downgrades Oak Street Health (NYSE:OSH) from Outperform to Market Perform.
Raymond James Downgrades Cigna to Outperform, Announces $370 Price Target
Raymond James analyst John Ransom downgrades Cigna (NYSE:CI) from Strong Buy to Outperform and announces $370 price target.